HOPIN
23.3.2021 12:32:06 CET | Business Wire | Press release
Hopin , the leading virtual experience platform, announced today that it has acquired video hosting provider Streamable and video technology company Jamm . The technology from both companies will be integrated into Hopin’s current product offering and become the basis for the development of future video products and features. The acquisitions solidify Hopin’s focus to holistically improve its professional-grade video capabilities for organizers that host events on Hopin and to build out its suite of new, video-centric products.
“As the world reopens, high-quality virtual experiences will continue to be critical. Video will be the primary communication channel for businesses, creators and organizations to share experiences virtually, so these acquisitions are a natural next step,” said Johnny Boufarhat, founder and CEO of Hopin. “The technology and resources from Jamm and Streamable will become foundational components to future products and the entire Hopin video experience — from production and video quality to how our customers can collaborate and distribute content.”
Streamable is a popular video hosting site founded by Armen Petrosian in 2014. Petrosian has grown Streamable for the past seven years to become a leading video hosting service that has 75,000 new video uploads per day and over 5,000 paying customers in more than 100 countries. Petrosian will continue to lead Streamable’s business and help build new products at Hopin.
“At Streamable, we’ve always wanted to build products that are simple and easy to use for everyone and we recognized that Hopin’s goal to bring accessibility to events and meetings dovetailed nicely with our own goals,” said Armen Petrosian, founder and CEO of Streamable. “The first priority for Streamable will be to invest in our product suite and ultimately integrate the Streamable platform into Hopin’s future suite of products.”
Jamm was founded in 2019 by Badri Rajasekar to create a lightweight way for users to collaborate over video. Rajasekar is an expert in video technology and was previously CTO of the real-time communication API platform TokBox prior to Jamm. TokBox was acquired by Telefonica in 2012 and subsequently spun out to Vonage in 2018. Jamm hosts a number of customers including Swoop, SignEasy, Deepsource, Stackery and others across a range of industry verticals such as fintech, gaming, education and more. Rajasekar will play a key role in helping develop new features and products in-house at Hopin.
“Since I founded Jamm in 2019, we’ve seen growing interest as more businesses pursue a remote-work strategy. I’ve witnessed firsthand how productive remote teams can become when they have a video solution that’s lightweight and collaborative,” said Jamm founder and CEO Badri Rajasekar. “I’m excited to bring my expertise to Hopin and build upon the great products Johnny has already developed, to make virtual experiences even easier for Hopin customers.”
Hopin continues to see impressive demand for its products and services. In a little over a year, Hopin has grown to millions of users and more than 90,000 organizers hosting events. The two acquisitions are a continuation of Hopin’s rapid growth, as it looks to its future product roadmap to drive and meet the demand of current and future customers. Hopin recently acquired mobile app development company Topi and video streaming company StreamYard, adding StreamYard’s 3.6 million video content creators to its base. Hopin has also raised $570M to-date, with its most recent raise a $400M Series C earlier this month, co-led by Andreessen Horowitz and General Catalyst.
About Hopin
Founded in 2019, Hopin enables brands and communities to create all-in-one live video experiences for their audiences. Through its platforms, attendees can learn, interact, and connect with people from anywhere in the world. With Hopin, you can create live virtual and hybrid events that are interactive and immersive. Hopin acquired StreamYard, a leading video streaming studio, in 2020. Hopin is a remote-first company headquartered in London, with employees in 42 countries. Learn more at hopin.com.
About Streamable
Streamable is an internet video streaming company that powers innovative video experiences for thousands of creators and businesses all around the world. With Streamable, you can upload, crop, trim, embed and share videos — all without ever leaving your browser. Whether you’re just getting started or you have advanced video hosting and editing needs, Streamable is perfect for you. Get started today at https://streamable.com .
About Jamm
Jamm is a virtual workplace application that enables lightweight voice and video collaboration for remote teams. Jamm aims to unlock more spontaneous connections and short bursty conversations in the workplace. With powerful collaboration features like screen-sharing, white-boarding, recorded video stories and more — unlock your team’s full potential with Jamm. Try it out now at https://jamm.app .
View source version on businesswire.com: https://www.businesswire.com/news/home/20210323005439/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press release
- Vertex is on track for the U.S. FDA Prescription Drug User Fee Act (PDUFA) date of November 30 for potential accelerated approval of povetacicept –- Data published in NEJM and presented at ASN highlight povetacicept’s unique trifecta of efficacy, favorable safety, and the simplicity of dosing at-home every 4 weeks with a low-volume autoinjector –- Data presented at ASN include a qualitative study examining patient perspectives on current and emerging IgAN therapies, showing that 96% of participants preferred an autoinjector over a prefilled syringe, and 80% of participants preferred dosing every 4 weeks versus weekly dosing - - New clinical studies of povetacicept underway including a study evaluating patient experience on povetacicept administered via autoinjector - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Soc
BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press release
New data from HERIZON-GEA-01 Phase 3 trial show 36-month overall survival of nearly 40% with TEVIMBRA plus ZIIHERA and chemotherapy, and median OS reaching 27 monthsTEVIMBRA-containing arm was associated with a four-month longer median OS compared with ZIIHERA plus chemotherapy BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne,
Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:10:00 CEST | Press release
Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com
inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press release
Collaboration will establish the roadmap for bringing Pony.ai robotaxis to Kazakhstan on the inDrive ride-hailing platform, leveraging the NVIDIA Hyperion and the NVIDIA Halos safety system. inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a lea
Brenus Pharma's Novel In Vivo Immunotherapy STC-1010 Shows Safety, Activating T Cells in First-Line MSS Metastatic Colorectal Cancers With 2 Complete Responses.23.10.2026 14:50:00 CEST | Press release
Phase Ia BreAK CRC-001 at ESMO 2026: 43% of patients, all initially unresectable, became eligible for surgery Poster 1023P – Developmental Therapeutics Brenus Pharma, a clinical-stage biotech company, announced first data from the Phase Ia dose escalation of BreAK CRC-001. Nine unresectable patients were treated; 89% had liver metastases and 89% KRAS-mutant tumors, a population refractory to immunotherapy. Median follow-up: 8 months (1–14; data cut-off 6/08/2026). 95% of metastatic colorectal cancers are pMMR/MSS tumors, poorly immunogenic and resistant to immunotherapy. STC-1010, the company’s lead in vivo DC-engager, is designed to make these “cold” tumors visible to immune cells. Safety: no dose-limiting toxicity, only grade 1–2 related adverse events. Clinical activity (seven evaluable patients, RECIST 1.1): 100% disease control, 57% objective response rate (4/7). 43% of patients became operable (3/7): two with no evidence of disease afterward. Molecular profile: ctDNA dropped by u
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom